Market Insights Snapshot
In the Tincture & Sublingual category, Oregon based cannabis brand Mama Lou's demonstrated a notable upward trend from July to September 2023. Initially ranked 16th in July, the brand managed to improve its position to 13th by September. This upward movement in rankings, even in the face of stiff competition, indicates a positive growth trajectory for Mama Lou's in this category. However, it's worth noting that the brand couldn't improve its ranking further in October, maintaining its 13th position from the previous month.
When it comes to sales, Mama Lou's showed a significant increase from July to September 2023, with sales jumping from $7499 to $13484. This substantial rise in sales correlates with the brand's improved ranking during this period. However, despite maintaining its ranking in October, the brand experienced a slight dip in sales, down to $12936. This could suggest a potential stabilization in the brand's market share, or it might be a temporary fluctuation. Regardless, keeping an eye on the brand's performance in the coming months will provide a clearer picture.
In the Tincture & Sublingual category for Oregon, Mama Lou's has shown a steady climb in rank from July to September 2023, moving from 16th to 13th place. This upward trend suggests a growing consumer preference for the brand, despite fierce competition. Notably, Korova and Dr. Jolly's have maintained higher ranks, but their positions have been somewhat unstable, with Korova dropping from 8th to 12th place and Dr. Jolly's fluctuating around 12th place. On the other hand, Elysium Fields and Crown B Alchemy have been trailing behind Mama Lou's, with Elysium Fields moving from 15th to 14th place and Crown B Alchemy wavering around 15th place. The sales trend for these brands mirrors their ranking, with Mama Lou's showing a consistent increase in sales, while the others have experienced more fluctuations.
In October 2023, Mama Lou's top-performing product was the CBD/THC/CBG 1:1:1 Calm Tincture, which ranked first with notable sales of 132 units. This product showed a consistent improvement in rankings over the past three months, moving from the 5th position in July to the top spot. The second highest seller was the CBD/THC 1:1 RSO Syringe, maintaining its 4th position from the previous two months. The Energy Tincture, which was the top seller in September, dropped to the third position in October. Rounding out the top five were the CBD/THC 1:1 Wellness Tincture and the THC RSO, ranking fourth and fifth respectively.